Serum-free culture medium for mesenchymal stem cells and use thereof

By adding platelet lysates and other components to the culture medium of mesenchymal stem cells, the problem of poor three-dimensional culture effect of existing serum-free culture media is solved, high-quality cell proliferation and safety are achieved, and serum-related risk.

WO2024251234A1PCT designated stage expired Publication Date: 2024-12-12BEIJING CYTONICHE BIOTECH CO LTD

Patent Information

Application Number
PCT/CN2024/097949
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-06-08
Filing Date
2024-06-07
Publication Date
2024-12-12

AI Technical Summary

Technical Problem

Existing serum-free culture medium of mesenchymal stem cells is not effective in three-dimensional large-scale culture, with a risk of contaminating exogenous viruses and pathogenic factors, and the inconsistency of unknown components in the serum leads to poor reproducibility of experimental results and may cause allergic reactions. .

Method used

Use serum-free culture medium containing platelet lysates, combined with basal culture medium, L-glutamine, hydrocortisone and EGF, etc., and is suitable for two-dimensional and three-dimensional culture, improving cell viability and proliferation quality, ensuring safety Highly sexual.

Benefits of technology

It significantly improves the survival rate and proliferation quality of mesenchymal stem cells in two-dimensional and three-dimensional cultures, avoids the risk of contamination caused by serum, achieves high-quality large-scale cell amplification, and improves the reproducibility of experimental results. and security.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure PCTCN2024097949-FTAPPB-I100001
    Figure PCTCN2024097949-FTAPPB-I100001
  • Figure PCTCN2024097949-FTAPPB-I100002
    Figure PCTCN2024097949-FTAPPB-I100002
  • Figure PCTCN2024097949-FTAPPB-I100003
    Figure PCTCN2024097949-FTAPPB-I100003
Patent Text Reader

Abstract

A serum-free culture medium for mesenchymal stem cells. Specifically, the serum-free culture medium comprises a basic culture medium, a platelet lysate, and other culture components such as but not limited to L-glutamine, hydrocortisone, a growth factor, etc. The serum-free culture medium for stem cells is suitable for two-dimensional culture of mesenchymal stem cells while being especially suitable for three-dimensional culture of mesenchymal stem cells, and has the advantages of high stem cell amplification quality, large quantity, high safety, etc.
Need to check novelty before this filing date? Find Prior Art

Description

Serum-free culture medium for mesenchymal stem cells and its application

[0001] This application claims priority to Chinese patent application No. 202310674353.9, filed on June 8, 2023, entitled “Mesenchymal stem cell serum-free culture medium and its application,” which is hereby incorporated by reference in its entirety. Technical Field

[0002] The present invention belongs to the technical field of cell culture, and in particular relates to a serum-free culture medium for mesenchymal stem cells containing platelet lysate, and a preparation method and application thereof. Background Art

[0003] Mesenchymal stem cells (MSCs), also known as multipotent stromal cells, are a type of multipotent stem cell belonging to the mesoderm. They are primarily found in connective tissues and organ mesenchyme, including bone marrow, umbilical cord, adipose tissue, mucosa, bone, muscle, lung, liver, pancreas, and other tissues, as well as amniotic fluid, amniotic membrane, and placenta. Under suitable conditions, they can differentiate into various tissue cell types, including fat, bone, and cartilage. Bone marrow mesenchymal stem cells (BM-MSCs) were first discovered by Freidenstein in 1976. Subsequent studies have shown that BM-MSCs possess multipotential differentiation potential, support hematopoiesis, promote stem cell engraftment, regulate immunity, and self-replication. These stem cells have garnered widespread attention and are considered the most promising stem cell product for clinical application. Because BM-MSCs can be isolated and extracted from umbilical cord tissue without causing any damage, and their abundance, high quality, and purity make them the most valuable stem cells for clinical application and preservation.

[0004] Currently, stem cell culture mainly relies on traditional two-dimensional culture, which is equivalent to supporting stem cell growth only on one plane. The proliferation efficiency and space utilization are very low, which cannot meet the growing demand for large-dose applications of clinical stem cells. Compared with two-dimensional planar cell culture technology, three-dimensional culture co-cultures a three-dimensional structure matrix with cells in vitro to form three-dimensional cell aggregates, allowing cells to grow, differentiate and migrate in three dimensions in vitro, more realistically simulating the living environment in the body, and more conducive to cell proliferation, survival and the maintenance of their own characteristics. Cells have different nutritional requirements under different culture conditions. Therefore, suitable three-dimensional culture culture technology requires a suitable three-dimensional culture medium to achieve the optimal large-scale production process.

[0005] Most culture media used for in vitro culturing of mesenchymal stem cells require serum supplementation, which poses a risk of contamination with exogenous viruses and pathogenic factors during the cell culture process. Furthermore, due to the high number of unknown components in serum, the bioactive factors vary between batches of serum, leading to poor reproducibility of products and experimental results. Residual serum can also easily cause allergic reactions in recipients, posing a significant challenge to clinical research. To overcome these drawbacks of serum, the use of serum-free culture media is essential for cell culture.

[0006] Platelet lysate (HPLs) is a xeno-free, animal serum-free cell culture medium supplement derived from human platelets. HPLs can be collected from blood banks, where expired platelets unsuitable for transfusion are available. HPLs contain a large number of substances such as cytokines, growth factors, and proteins that can promote the growth of MSCs while maintaining their differentiation potential and immunomodulatory properties. Currently, the vast majority of serum-free culture media for mesenchymal stem cells on the market are designed for two-dimensional culture and are ineffective for large-scale three-dimensional culture. The present invention aims to develop a serum-free culture medium based on platelet lysate that is suitable for both two-dimensional and three-dimensional culture, achieving high-quality and quantitative cell expansion with high safety.

[0007] Summary of the Invention

[0008] The purpose of the present invention is to provide a novel serum-free culture medium for mesenchymal stem cells. The culture medium is serum-free and animal-derived, and can significantly improve the viability, proliferation and cell quality of mesenchymal stem cells in two-dimensional or three-dimensional culture, thereby solving the technical problem that existing serum-free culture medium for mesenchymal stem cells in the prior art is not effective when used for large-scale three-dimensional culture.

[0009] In one aspect, the present invention provides a serum-free culture medium for mesenchymal stem cells, comprising the following components in the following amounts:

[0010] In some embodiments, the mesenchymal stem cell serum-free culture medium further comprises one or more components selected from the following group, the contents of which are as follows:

[0011] In some embodiments, the basal culture medium is selected from the group consisting of α-MEM medium, D / F12 medium and DMEM medium, and preferably the basal culture medium is α-MEM medium.

[0012] In some embodiments, the content of the platelet lysate is 5% (v / v).

[0013] In some embodiments, the content of L-glutamine is 4 mM.

[0014] In some embodiments, the content of hydrocortisone is 500 μg / L.

[0015] In some embodiments, the content of EGF is 5-20 ng / ml.

[0016] In another aspect, the present invention provides a method for preparing a serum-free culture medium for mesenchymal stem cells, comprising:

[0017] 1) adding the other components except the platelet lysate to the basal culture medium in proportion; and

[0018] 2) After filtration, add platelet lysate in proportion.

[0019] In some alternative embodiments, the present invention provides a method for preparing a serum-free culture medium for mesenchymal stem cells, comprising:

[0020] 1) mixing the other components except the basal medium in proportion to prepare a nutrient supplement composition; and

[0021] 2) adding the nutrient supplement preparation prepared in step 1) into the basal culture medium preparation.

[0022] In another aspect, the present invention provides a method for culturing mesenchymal stem cells, wherein the mesenchymal stem cell serum-free culture medium of the present invention is used for culturing.

[0023] In some embodiments, the culture method is a two-dimensional culture method, comprising the following steps:

[0024] 1) Mixing the cell suspension containing cells with the complete medium of mesenchymal stem cells;

[0025] 2) Collect cells and resuspend them in mesenchymal stem cell complete medium;

[0026] 3) seeding the cells into a cell culture container, adding complete mesenchymal stem cell culture medium, and culturing in an incubator; and

[0027] 4) Harvest cells.

[0028] The complete mesenchymal stem cell culture medium is the serum-free mesenchymal stem cell culture medium of the present invention, and its composition is as described above.

[0029] In some embodiments, the culture method is a three-dimensional culture method, comprising the following steps:

[0030] 1) Preparing microcarriers: placing the microcarriers in a culture vessel. Optionally, the microcarriers are pre-swollen with liquid and then transferred to the culture vessel. Complete mesenchymal stem cell culture medium is added to uniformly disperse the microcarriers.

[0031] 2) Cell inoculation and culture: adding the cell suspension into a culture container and culturing in an incubator; and

[0032] 3) Harvest cells.

[0033] The complete mesenchymal stem cell culture medium is the serum-free mesenchymal stem cell culture medium of the present invention, and its composition is as described above.

[0034] In another aspect, the present invention provides a use of a serum-free medium for mesenchymal stem cells in culturing mesenchymal stem cells. In some embodiments, the culture is a two-dimensional culture. In some embodiments, the culture is a three-dimensional culture.

[0035] The beneficial effects of the present invention are:

[0036] 1. The culture medium of the present invention does not contain components derived from serum, thus avoiding the risks of contamination with exogenous viruses and pathogenic factors, poor reproducibility of products and experimental results, and the risk of allergic reactions caused by serum;

[0037] 2. While being suitable for two-dimensional culture of mesenchymal stem cells, the culture medium of the present invention is also particularly suitable for three-dimensional culture of mesenchymal stem cells, achieving large-scale, high-quality expansion of mesenchymal stem cells and having the advantage of high safety.

[0038] BRIEF DESCRIPTION OF THE DRAWINGS

[0039] FIG1 shows the cell viability during continuous culture in Example 5.

[0040] FIG2 shows the proliferation times of cells in continuous culture in Example 5.

[0041] FIG3 shows the diameter of cells continuously cultured in Example 5. FIG.

[0042] FIG4 shows a microscopic image of the continuous cell culture in Example 5. ...

[0043] FIG5 shows the cell staining results on day 1 and day 4 of three-dimensional culture P7 in Example 7.

[0044] FIG6 shows the cell staining results on the 1st and 4th days of three-dimensional culture in Example 8. DETAILED DESCRIPTION

[0045] Unless otherwise defined, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

[0046] When used herein, the terms "comprising" are intended to specify the presence of stated features, integers, components or steps, but they do not preclude the presence or addition of one or more other features, integers, components, steps or groups thereof.

[0047] Mesenchymal Stem Cell Serum-Free Medium

[0048] In one aspect, the present invention provides a serum-free culture medium for mesenchymal stem cells, which can be used for two-dimensional culture and three-dimensional culture of mesenchymal stem cells.

[0049] As used herein, the term "stem cell" refers to a type of multipotent cell with the ability to self-replicate. Under certain conditions, stem cells can differentiate into a variety of functional cells. The term "mesenchymal stem cell" refers to an important member of the stem cell family, which originates from the early developmental mesoderm and is a multipotent stem cell. It was originally discovered in the bone marrow and has the characteristics of multidirectional differentiation potential, hematopoietic support and promotion of stem cell implantation, immune regulation and self-replication. Mesenchymal stem cells include bone marrow mesenchymal stem cells, dental pulp mesenchymal stem cells, adipose mesenchymal stem cells, synovial mesenchymal stem cells, bone mesenchymal stem cells, muscle mesenchymal stem cells, lung mesenchymal stem cells, liver mesenchymal stem cells, pancreatic mesenchymal stem cells, amniotic fluid mesenchymal stem cells, umbilical cord mesenchymal stem cells, etc. The term "umbilical cord mesenchymal stem cells" refers to mesenchymal stem cells derived from the umbilical cord. The term "adipose mesenchymal stem cells" refers to mesenchymal stem cells derived from adipose.

[0050] As used herein, the term "serum-free medium" refers to a cell culture medium that is not supplemented with serum proteins such as fetal bovine serum. Serum-free medium is well known in the art.

[0051] The serum-free culture medium for mesenchymal stem cells of the present invention comprises basal medium, about 88-99% (v / v); platelet lysate, about 1-12% (v / v); L-glutamine, about 2-4 mM; and hydrocortisone, about 0.05-5000 μg / L.

[0052] When used in this article, the term "basal medium" refers to the starting medium to which cells are added and cultured.Basic medium is a solution of nutrients that nourish the cells that grow. Typically, basal medium provides the essential and non-essential amino acids, vitamins, energy sources, lipids and trace elements that cells need for minimal growth and / or survival. In some embodiments, basal medium is a commercially available culture medium or a culture medium known in the art that can maintain the growth or proliferation of mammalian cells. Non-limiting examples of basal medium include but are not limited to DMEM, F12, MEM, α-MEM, MEGM, RPMI-1640 and combinations thereof. In some embodiments, the basal medium includes D / F12 (e.g., 1:1 mixing ratio), α-MEM+DMEM (e.g., 1:1 mixing ratio) and α-MEM. In a preferred embodiment, the basal medium is α-MEM. In some embodiments, in the serum-free culture medium for mesenchymal stem cells of the present invention, the basal medium accounts for about 88-99% (v / v) by volume, for example, about 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or any value within a range with any of the above values ​​as endpoints. In some embodiments, in the serum-free culture medium for mesenchymal stem cells of the present invention, the basal medium accounts for about 88-97% (v / v) by volume, for example, about 88-95% (v / v), about 88-93% (v / v), about 88-92% (v / v), about 88-91% (v / v), about 89-91% (v / v), about 90% (v / v), etc., based on the total volume of the serum-free culture medium for mesenchymal stem cells.

[0053] As used herein, the term "platelet lysate" refers to a product that can be obtained from platelets. Platelets can be obtained from a donor, preferably a human donor, and can be separated and pooled from multiple collection units of whole blood, or collected by plateletpheresis: blood is obtained from a donor and passed through a device that removes platelets. After separation, the platelets are typically lysed, for example, by one or more freeze / thaw cycles. The platelet lysate used in the present invention can be a commercially available platelet lysate product that can be purchased commercially, such as the platelet lysate product EliteGro-adv available from EliteCell Biomedical Corp. In some embodiments, the serum-free medium for mesenchymal stem cells of the present invention comprises about 1-12% (v / v) of platelet lysate by volume, for example, about 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 5.5%, 6%, 6.5%, 7%, 7.5%, 8%, 9%, 10%, 11%, 12%, or any value within a range having any of the above values ​​as endpoints. In some embodiments, the serum-free medium for mesenchymal stem cells of the present invention comprises about 2-10% (v / v) of platelet lysate by volume, for example, about 2.5-10% (v / v), about 2.5-7.5% (v / v), about 3.5-6.5% (v / v), about 4.5-5.5% (v / v), about 5% (v / v), etc. In a preferred embodiment, in the serum-free culture medium for mesenchymal stem cells of the present invention, the platelet lysate accounts for about 5% (v / v) in terms of volume ratio calculated based on the total volume of the serum-free culture medium for mesenchymal stem cells.

[0054] During cell culture, most cells have a high requirement for glutamine, as it is used by cells as both an energy source and a carbon source. It is an essential amino acid for the synthesis of nucleic acids and proteins. In the absence of glutamine, cells grow poorly and die. The glutamine that cells can utilize is the L-isomer; D-glutamine cannot be utilized. In some embodiments, the L-glutamine content in the serum-free culture medium for mesenchymal stem cells of the present invention is approximately 2-4 mM, for example, approximately 2 mM, 2.5 mM, 3 mM, 3.5 mM, 4 mM, or any value within a range consisting of these values. In a preferred embodiment, the L-glutamine content in the serum-free culture medium for mesenchymal stem cells of the present invention is approximately 4 mM.

[0055] When used in this article, the term "hydrocortisone" is also referred to as cortisone, and refers to an adrenocortical hormone agent with a glucocorticoid effect. In mesenchymal stem cell culture, hydrocortisone is a commonly used additive that can affect the signal transduction pathway of the cell, thereby affecting the function of the cell. It can also inhibit the immune response and inflammatory response of the cell, thereby reducing the stress to which the cell is subjected in culture, and improving the survival rate and growth rate of the stem cell. In some embodiments, in the mesenchymal stem cell serum-free culture medium of the present invention, the content of hydrocortisone is about 0.05-5000 μg / L, for example, about 0.05 μg / L, 0.5 μg / L, 5 μg / L, 50 μg / L, 500 μg / L, 1000 μg / L, 2000 μg / L, 3000 μg / L, 4000 μg / L, 5000 μg / L, or any value within the range of the above arbitrary numerical value being endpoint. In some embodiments, the content of hydrocortisone in the serum-free culture medium for mesenchymal stem cells of the present invention is about 5-5000 μg / L, for example, about 100-1000 μg / L, for example, about 100 μg / L, 200 μg / L, 300 μg / L, 400 μg / L, 500 μg / L, 600 μg / L, 700 μg / L, 800 μg / L, 900 μg / L, 1000 μg / L. In a preferred embodiment, the content of hydrocortisone in the serum-free culture medium for mesenchymal stem cells of the present invention is about 500 μg / L.

[0056] The mesenchymal stem cell serum-free culture medium of the present invention may also include growth factors. Growth factors are supplementary factors necessary to maintain the survival, proliferation and differentiation of cells cultured in vitro. Growth factors are effective mitogens that can shorten the doubling time of cell populations. According to their chemical properties, they can be divided into polypeptide growth factors and steroid growth factors. Growth factors that can be added to the mesenchymal stem cell serum-free culture medium of the present invention include but are not limited to polypeptide growth factors and steroid growth factors, such as natural growth factors or corresponding recombinant growth factors obtained by genetic recombination. In some embodiments, the mesenchymal stem cell serum-free culture medium of the present invention includes one or more growth factors selected from the group consisting of epidermal growth factor (EGF); fibroblast growth factor (FGF), such as basic fibroblast growth factor (bFGF); and nerve growth factor (NGF). In some embodiments, the mesenchymal stem cell serum-free culture medium of the present invention includes epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF). In some embodiments, in the serum-free medium for mesenchymal stem cells of the present invention, the content of EGF is about 0-20 ng / ml, for example, about 0 ng / ml, 1 ng / ml, 2 ng / ml, 3 ng / ml, 4 ng / ml, 5 ng / ml, 6 ng / ml, 7 ng / ml, 8 ng / ml, 9 ng / ml, 10 ng / ml, 11 ng / ml, 12 ng / ml, 13 ng / ml, 14 ng / ml, 15 ng / ml, 16 ng / ml, 17 ng / ml, 18 ng / ml, 19 ng / ml, 20 ng / ml, or any value within the range of any of the above values ​​as endpoints. In some embodiments, in the serum-free medium for mesenchymal stem cells of the present invention, the content of EGF is about 5-20 ng / ml. In a preferred embodiment, in the serum-free medium for mesenchymal stem cells of the present invention, the content of EGF is about 20 ng / ml. In some embodiments, the content of bFGF in the serum-free culture medium for mesenchymal stem cells of the present invention is about 5-20 ng / ml, for example, about 5 ng / ml, 6 ng / ml, 7 ng / ml, 8 ng / ml, 9 ng / ml, 10 ng / ml, 11 ng / ml, 12 ng / ml, 13 ng / ml, 14 ng / ml, 15 ng / ml, 16 ng / ml, 17 ng / ml, 18 ng / ml, 19 ng / ml, 20 ng / ml, or any value within a range having any of the above values ​​as endpoints. In a preferred embodiment, the content of bFGF in the serum-free culture medium for mesenchymal stem cells of the present invention is about 20 ng / ml.

[0057] The serum-free medium for mesenchymal stem cells of the present invention may further include other supplementary factors. For example, the supplementary factors that can be added to the serum-free medium for mesenchymal stem cells of the present invention include, but are not limited to, hormones, binding proteins, adhesion factors, and other additive factors.

[0058] In some embodiments, the serum-free culture medium for mesenchymal stem cells of the present invention includes hormones, such as insulin, growth hormone, glucagon, etc. Almost all cell lines require insulin, which is a polypeptide that can bind to the insulin receptor on cells to form a complex, promote the synthesis of RNA, protein, and fatty acids, and promote cell apoptosis, making it an important cell survival factor.

[0059] In some embodiments, the serum-free culture medium for mesenchymal stem cells of the present invention includes binding proteins, such as transferrin and albumin. Most mammalian cells have specific transferrin receptors. The binding of this receptor to a complex of transferrin and iron ions is the primary source of iron, the essential trace element, for cells. Furthermore, transferrin also has growth factor properties and can bind to other trace elements, such as vanadium. Different cells require different amounts of transferrin. Albumin is also a commonly added factor in serum-free culture medium. It stabilizes and regulates the activity of vitamins, lipids, hormones, metal ions, and growth factors in serum-free culture medium by binding to these substances. It also binds toxins and mitigates the effects of proteases on cells. In some embodiments, the albumin content in the serum-free culture medium for mesenchymal stem cells of the present invention is approximately 0.5-1.0 g / L, for example, approximately 0.5 g / L, 0.6 g / L, 0.7 g / L, 0.8 g / L, 0.9 g / L, 1.0 g / L, or any value within a range defined by any of the aforementioned values.

[0060] In some embodiments, when adding components to the serum-free culture medium for mesenchymal stem cells of the present invention, a component complex can be added, such as a complex comprising a hormone, such as insulin, and a binding protein, such as transferrin. In some specific embodiments, the component complex is an ITS, including, but not limited to, ITS-X, ITS-G, and ITS-E. In some embodiments, the serum-free culture medium for mesenchymal stem cells of the present invention comprises ITS-X. The ITS-X that can be added to the serum-free culture medium for mesenchymal stem cells of the present invention can be a commercially available ITS-X product. In some embodiments, the content of ITS-X in the serum-free culture medium for mesenchymal stem cells of the present invention is approximately 0.8-1.2% (v / v), calculated by volume ratio based on the total volume of the serum-free culture medium for mesenchymal stem cells, such as approximately 0.8% (v / v), 0.9% (v / v), 1.0% (v / v), 1.1% (v / v), 1.2% (v / v), or any value within a range having any of the aforementioned values ​​as endpoints.

[0061] In some embodiments, the serum-free culture medium for mesenchymal stem cells of the present invention further comprises other supplementary factors, such as amino acids, vitamins, glucose, and salts including inorganic salts and organic salts.

[0062] Amino acids are the basic units for synthesizing proteins. The mesenchymal stem cell serum-free culture medium of the present invention may include essential amino acids and non-essential amino acids that the cells themselves cannot synthesize and can synthesize to meet the needs of cell growth. Those skilled in the art are familiar with the relevant knowledge of non-essential amino acids used in cell culture. The non-essential amino acids that can be added to the mesenchymal stem cell serum-free culture medium of the present invention can be commercially available non-essential amino acid products that can be purchased commercially, such as the non-essential amino acid products (Article No.: M7145) that can be provided by Sigma. In some embodiments, in the mesenchymal stem cell serum-free culture medium of the present invention, the content of non-essential amino acids is about 0.1-1.0mM, for example, about 0.1mM, 0.2mM, 0.3mM, 0.4mM, 0.5mM, 0.6mM, 0.7mM, 0.8mM, 0.9mM, 1.0mM, or any value within the range of any of the above numerical values ​​as endpoints.

[0063] Vitamins are a class of biologically active substances that maintain cell growth and play a significant role in cellular metabolism. They mostly form prosthetic groups or coenzymes for enzymes in cells. Without vitamins, enzymes are inactive and metabolic activity cannot proceed. The vitamins that can be added to the mesenchymal stem cell serum-free culture medium of the present invention can be multivitamins, such as commercially available multivitamin products, such as the MEM vitamin solution product (Cat. No. S420JV) provided by Shanghai Yuanpei Biotechnology Co., Ltd. In some embodiments, the vitamin content in the mesenchymal stem cell serum-free culture medium of the present invention is approximately 0.8-1.2% (v / v), calculated by volume ratio based on the total volume of the mesenchymal stem cell serum-free culture medium, for example, approximately 0.8% (v / v), 0.9% (v / v), 1.0% (v / v), 1.1% (v / v), 1.2% (v / v), or any value within a range having any of the aforementioned values ​​as endpoints.

[0064] Glucose provides an energy source for mesenchymal stem cells to grow in the culture medium. In some embodiments, in the serum-free culture medium for mesenchymal stem cells of the present invention, the content of glucose is about 11-27 mM, for example, about 11 mM, 12 mM, 13 mM, 14 mM, 15 mM, 16 mM, 17 mM, 18 mM, 19 mM, 20 mM, 21 mM, 22 mM, 23 mM, 24 mM, 25 mM, 26 mM, 27 mM, or any value within a range having any of the above values ​​as endpoints.

[0065] Salts such as inorganic salts or organic salts can maintain the osmotic pressure balance of the culture medium and participate in the metabolic activities of cells. + , K + , Ca 2+ Mg 2+ wait. Na + It is the most important cation in the extracellular fluid and plays a decisive role in maintaining the constant osmotic pressure. + Mainly distributed in intracellular fluid, intracellular K + It is necessary for the activation of certain enzymes and is also extremely important in regulating the acid-base balance of the intracellular environment. 2+ Its role in the extracellular fluid is to adhere cells within the tissue to each other and to participate in many important cell physiological activities within the cell, such as conduction and muscle cell contraction. 2+ Phosphorus is an important component of the extracellular matrix and plays a vital role in the stable binding between cells. Phosphorus compounds play an important role in the regulation of cellular metabolism and physiological functions.

[0066] In some embodiments, sodium pyruvate is included in the serum-free culture medium for mesenchymal stem cells of the present invention. In some embodiments, the content of sodium pyruvate in the serum-free culture medium for mesenchymal stem cells of the present invention is about 1-2 mM, for example, about 1 mM, 2 mM, or any value within a range consisting of any of the above values ​​as endpoints.

[0067] In some embodiments, Hepes is included in the serum-free culture medium for mesenchymal stem cells of the present invention. In some embodiments, the content of Hepes in the serum-free culture medium for mesenchymal stem cells of the present invention is about 10-25 mM, for example, about 10 mM, 11 mM, 12 mM, 13 mM, 14 mM, 15 mM, 16 mM, 17 mM, 18 mM, 19 mM, 20 mM, 21 mM, 22 mM, 23 mM, 24 mM, 25 mM, or any value within a range consisting of any of the above values ​​as endpoints.

[0068] In some embodiments, the mesenchymal stem cell serum-free culture medium of the present invention further comprises one or more components selected from the following group: sodium pyruvate, 1-2 mM; EGF, 0-20 ng / ml or 5-20 ng / ml; bFGF, 5-20 ng / ml; ITS-X, 0.8-1.2% (v / v); glucose, 11-27 mM; albumin, 0.5-1.0 g / L; vitamins, 0.8-1.2% (v / v); non-essential amino acids, 0.1-1.0 mM; and Hepes, 10-25 mM.

[0069] In some embodiments, the serum-free medium for mesenchymal stem cells of the present invention optionally further comprises a balance of water. It will be appreciated by those skilled in the art that, during the preparation of the serum-free medium, the volume obtained after preparation may be less than the sum of the volumes of the individual components due to factors such as the mixing and miscibility of liquids and the dissolution of solid components in liquid components. In such cases, the serum-free medium for mesenchymal stem cells having the desired total volume can be obtained by supplementing the balance of water.

[0070] Those skilled in the art will appreciate that the components contained in the serum-free culture medium for mesenchymal stem cells of the present invention may be commercially available products.

[0071] In some embodiments, the serum-free culture medium for mesenchymal stem cells of the present invention has the following composition:

[0072] In some embodiments, the serum-free culture medium for mesenchymal stem cells of the present invention has the following composition:

[0073] In some embodiments, the serum-free medium for mesenchymal stem cells of the present invention is a two-component formulation. The two components are stored separately and then mixed before use for ready-to-use preparation. In some embodiments, the serum-free medium for mesenchymal stem cells of the present invention is a two-component formulation, wherein the first component is a basal medium component, including a basal medium; and the second component is a nutrient supplement component, including other components in addition to the basal medium. The amounts of the components in each component are as defined herein.

[0074] In some embodiments, the two components are stored separately, wherein the basal medium component is stored at 2-8°C, and the nutrient supplement component is stored at -18 to -22°C, for example, -20°C.

[0075] Preparation of serum-free culture medium for mesenchymal stem cells

[0076] In another aspect, the present invention provides a method for preparing a serum-free culture medium for mesenchymal stem cells, comprising the following steps:

[0077] 1) adding the other components except the platelet lysate to the basal culture medium in proportion; and

[0078] 2) Add platelet lysate in proportion.

[0079] In some alternative embodiments, the present invention provides a method for preparing a serum-free culture medium for mesenchymal stem cells, comprising:

[0080] 1) mixing the other components except the basal medium in proportion to prepare a nutrient supplement composition; and

[0081] 2) adding the nutrient supplement preparation prepared in step 1) into the basal culture medium preparation.

[0082] In some embodiments, before addition, the components can be dissolved in water or an organic solvent, such as DMSO. In some embodiments, before addition, raw materials such as EGF, bFGF, glucose, albumin, glutamine, and / or sodium pyruvate are dissolved in water for cell culture. In some embodiments, before addition, hydrocortisone is dissolved in DMSO and / or alcohol.

[0083] In some embodiments, in each step of the above method, stirring or other means well known in the art are optionally performed during the addition of components to promote uniform mixing of the components.

[0084] In some embodiments, in each step of the above method, after the components are mixed, filtration can be optionally performed using a filtration method known in the art, such as filtration using a filter membrane. In some embodiments, filtration is performed using a filter membrane with a pore size of no greater than 0.22 μm. In some embodiments, filtration is performed using a filter membrane with a pore size of 0.22 μm, and in some embodiments, filtration is performed using a filter membrane with a pore size greater than 0.22 μm.

[0085] The mesenchymal stem cell serum-free culture medium of the present invention can be used immediately after preparation, or alternatively, can be stored at a low temperature for subsequent use. In some embodiments, the two components of the mesenchymal stem cell serum-free culture medium of the present invention are stored separately, wherein the basal medium component is stored at a temperature of 2-8°C, and the nutrient supplement component is stored at a temperature of -18 to -22°C, for example, -20°C.

[0086] Mesenchymal stem cell culture methods

[0087] In another aspect, the present invention provides a method for culturing mesenchymal stem cells, wherein the mesenchymal stem cell serum-free culture medium of the present invention is used for culturing.

[0088] The serum-free culture medium for mesenchymal stem cells of the present invention is not only applicable to the two-dimensional culture of mesenchymal stem cells, but also can be applied to the three-dimensional culture of mesenchymal stem cells, especially large-scale three-dimensional culture.

[0089] As used herein, the term "two-dimensional culture" refers to a culture in which cells are exposed to conditions that are compatible with cell growth and allow cells to grow in a monolayer. Devices suitable for such growth are referred to as "two-dimensional culture devices." Such devices typically have a flat growth surface. Non-limiting examples of devices used for two-dimensional culture are cell culture dishes and cell culture plates.

[0090] As used in this article, the term "three-dimensional culture" refers to the in vitro co-culturing of carriers with different materials having three-dimensional structures with various types of cells, so that the cells can migrate and grow in the three-dimensional spatial structure of the carrier, forming a three-dimensional cell-carrier complex, changing or reducing the cell's adhesion characteristics during the culture process, allowing the cells to obtain more living space in space, and reducing cell contact inhibition.

[0091] In the present invention, the cells to be cultured are stem cells, for example, mesenchymal stem cells, including but not limited to bone marrow mesenchymal stem cells, dental pulp mesenchymal stem cells, adipose mesenchymal stem cells, synovial mesenchymal stem cells, bone mesenchymal stem cells, muscle mesenchymal stem cells, lung mesenchymal stem cells, liver mesenchymal stem cells, pancreatic mesenchymal stem cells, amniotic fluid mesenchymal stem cells, umbilical cord mesenchymal stem cells, etc.

[0092] The two-dimensional culture method includes the following steps:

[0093] 1) Mixing the cell suspension containing cells with the complete medium of mesenchymal stem cells;

[0094] 2) Collect cells and resuspend them in mesenchymal stem cell complete medium;

[0095] 3) seeding the cells into a cell culture container, adding complete mesenchymal stem cell culture medium, and culturing in an incubator; and

[0096] 4) Harvest cells.

[0097] The mesenchymal stem cell complete culture medium is the mesenchymal stem cell serum-free culture medium of the present invention, and its composition is as described in the above aspects.

[0098] In some embodiments, the cells to be cultured may be cryopreserved cells. Prior to culturing, the cells are thawed according to procedures familiar to those skilled in the art, such as by placing the frozen cells in a 37°C water bath and shaking to thaw them. For example, the cells are removed from the cell suspension when ice crystals in the suspension are about to completely disappear, thereby obtaining a cell suspension containing the cells ready for further cell culture.

[0099] In some embodiments, the complete mesenchymal stem cell culture medium is prepared at room temperature and used immediately. In some embodiments, the complete mesenchymal stem cell culture medium is stored at low temperature and then returned to room temperature before use.

[0100] In some embodiments, the complete mesenchymal stem cell culture medium is added dropwise and mixed evenly with the cell suspension.

[0101] In some embodiments, cells are collected by centrifugation, for example, at 200×g for 5 minutes.

[0102] In some embodiments, the cells are accurately counted after being resuspended in complete mesenchymal stem cell culture medium.

[0103] In some embodiments, the seeding density can be 6000-10000 / cm 2 , for example 6000 / cm 2 , 7000 / cm 2 , 8000 / cm 2 , 9000 / cm 2 、10000 / cm 2 , or any value within the range of any of the above values ​​as endpoints. In a preferred embodiment, the seeding density is 8000 / cm 2 .

[0104] In some embodiments, the culture is performed using conventional incubation conditions in the art, for example, in an incubator at 37° C., 5% CO 2 concentration, and saturated humidity.

[0105] In some embodiments, the continuous culture time varies with the time required for the cell confluence to reach an appropriate standard, such as 75-90% or 80-85%. For example, the continuous culture can be 2 days, 3 days, 4 days, etc. After the cell confluence reaches an appropriate standard, such as 75-90% or 80-85%, the cells are harvested according to conventional methods in the art, or subsequent steps such as selection and passage can be performed.

[0106] In a specific embodiment, the two-dimensional culture method of mesenchymal stem cells of the present invention comprises the following steps.

[0107] Pipette the cell suspension into a centrifuge tube, add complete mesenchymal stem cell medium brought to room temperature, and gently mix. Collect the cells by centrifugation, then aspirate the supernatant and resuspend the cells in complete mesenchymal stem cell medium. Then, seed the cells into a cell culture vessel, add an appropriate amount of fresh complete mesenchymal stem cell medium brought to room temperature, and culture in an incubator. Continue culturing until the cells reach appropriate confluence and then choose to passage.

[0108] The three-dimensional culture method comprises the following steps,

[0109] 1) Preparing microcarriers: placing the microcarriers in a culture vessel. Optionally, the microcarriers are pre-swollen with liquid and then transferred to the culture vessel. Complete mesenchymal stem cell culture medium is added to uniformly disperse the microcarriers.

[0110] 2) Cell inoculation and culture: adding the cell suspension into a culture container and culturing in an incubator; and

[0111] 3) Harvest cells.

[0112] The complete mesenchymal stem cell culture medium is the serum-free mesenchymal stem cell culture medium of the present invention, and its composition is as described above.

[0113] In some embodiments, the cells to be cultured may be cryopreserved cells. Prior to culturing, the cells are thawed according to procedures familiar to those skilled in the art, such as by placing the frozen cells in a 37°C water bath and shaking to thaw them. For example, the cells are removed from the cell suspension when ice crystals in the suspension are about to completely disappear, thereby obtaining a cell suspension containing the cells ready for further cell culture.

[0114] In some embodiments, the complete mesenchymal stem cell culture medium is prepared at room temperature and used immediately. In some embodiments, the complete mesenchymal stem cell culture medium is stored at low temperature and then returned to room temperature before use.

[0115] In some embodiments, conventional reactors in the art are used for culture according to conventional three-dimensional culture conditions. In some embodiments, the reactor parameters are set to a combination of variable speed culture and constant speed culture, for example, 40 rpm for 5 minutes, 1 rpm for 2 hours, for 1 day. After optionally replenishing complete mesenchymal stem cell culture medium, the reactor is adjusted to a constant speed of 40 rpm and culture is continued for several days, for example, 1 day, 2 days, 3 days, or 4 days. The time to stop culture is determined based on the results of cell sampling and testing.

[0116] In some embodiments, cell sampling and detection can be performed using conventional procedures in the art. For example, a small amount of microcarrier suspension is pipetted using a sterile pipette and placed in a microplate, such as a 96-well plate, and cells are observed by fluorescent staining.

[0117] In some embodiments, cells can be harvested using conventional procedures in the art. In some specific embodiments, the microcarriers employed are those that can be lysed with a lysing solution. After the microcarriers are completely degraded, the cell suspension is collected, centrifuged, and the supernatant discarded to harvest the cells. Alternatively, the cells can be resuspended in PBS, centrifuged again, and the supernatant discarded, optionally repeating this process multiple times to harvest the cells. After harvesting the cells, they can be resuspended to a suitable density for later use.

[0118] In some embodiments, cell counting is optionally included to detect relevant parameters such as the number of viable cells, cell viability, and cell diameter. In a specific embodiment, a small amount of cell suspension that has been lysed and resuspended once is taken and placed on a cell counter for counting, and finally, relevant parameters such as the number of viable cells, cell viability, and cell diameter are detected.

[0119] In a specific embodiment, the three-dimensional culture method of mesenchymal stem cells of the present invention comprises the following steps:

[0120] 1. Microslide and cell preparation: Place the microslide into a culture flask, add complete mesenchymal stem cell culture medium, and shake the culture flask to evenly disperse the microslide.

[0121] 2. Cell seeding and culture: Add the cell suspension to a culture flask, add complete mesenchymal stem cell culture medium, and culture in an incubator. Optional supplementation of complete mesenchymal stem cell culture medium may be performed during this period.

[0122] 3. Optional cell sampling and observation: Use a sterile pipette to draw a small amount of microcarrier suspension into a microplate, and observe the cells by fluorescent staining;

[0123] 4. Cell harvesting: Stop stirring the bioreactor, wait for the microcarriers to settle, discard the supernatant, add lysis buffer for lysis and digestion, wait for the microcarriers to be completely degraded, collect the cell suspension, optionally perform centrifugation, discard the supernatant, resuspend the cells in PBS, centrifuge again, and discard the supernatant. Optionally, resuspend the cells to a suitable density as needed and set aside;

[0124] 5. Optional cell counting: Take a small amount of the cell suspension that has been lysed and resuspended once, place it on a cell counter for counting, and finally measure the number of living cells, cell viability, cell diameter and other related parameters.

[0125] Compared to two-dimensional cell culture, three-dimensional cell culture offers numerous advantages: 1. Closer emulation of the in vivo environment: Cells can form more complex tissue structures in three-dimensional structures, more closely resembling the internal human environment. This makes 3D cell cultures more biologically meaningful and clinically valuable. 2. Enhanced cell-cell and cell-matrix interactions: 3D culture allows for enhanced cell-cell and cell-matrix interactions, thereby better mimicking the in vivo biological environment, increasing intercellular communication and promoting plasticity in growth and differentiation. 3. Enhanced drug screening: 3D culture better mimics the in vivo biological environment, making it more suitable for drug screening. This method can help better predict the efficacy and safety of new drugs, thereby improving drug development efficiency. 4. Enhanced applications in tissue engineering and regenerative medicine: 3D culture provides improved models and methods for tissue engineering and regenerative medicine. 3D culture allows for the combination of multiple cell types into complex tissue structures, significantly enhancing the study of cell-cell interactions and cell differentiation. Furthermore, 3D culture offers improved methods for tissue repair and regeneration, such as tissue engineering using stem cells and pluripotent cells.

[0126] A three-dimensional culture system comprising microcarriers can be used when performing three-dimensional cell culture. As used herein, the term "microcarrier" refers to support matrix particles that allow adherent cells, such as mesenchymal stem cells, to grow in a bioreactor. In the present invention, microcarriers can be spheres, cylinders, or flat carriers. Microcarriers can be solid or porous. The size of the microcarrier can be 10-1000 microns, such as 20-1000 microns, 50-500 microns of porous microspheres, wherein a porous permeable structure consisting of several interconnected pores greater than 10 microns in diameter encapsulates the cells, just like the relationship between a honeycomb and a bee. The porous structure of the microcarrier provides a nest for the cells to protect them from adverse external factors.

[0127] Microcarrier can be made up of multiple different materials.In some embodiments, microcarrier is made up of non-biodegradable material, such as but not limited to cellulose, DEAE-dextran, hydroxylated methacrylate, polyacrylamide, polystyrene, plastics, glass, ceramics and silicone.In some embodiments, microcarrier is made up of biodegradable material, such as but not limited to collagen, alginate, dextran, gellan gum and gelatin.These microcarrier materials and different surface chemical properties can affect cell behavior, comprise form and proliferation.

[0128] Microcarriers that can be used for three-dimensional cell culture can be purchased commercially from manufacturers such as Global Cell Solutions, GE Healthcare, Cultispher Percell, SoloHill Engineering, Cytiva, and Beijing Huakan. In some embodiments, the microcarrier used in the three-dimensional culture is a three-dimensional porous microcarrier, preferably having a particle size of 80-400 μm and a pore size of 30-50 μm. The mesenchymal stem cell serum-free culture medium of the present invention can be applied to the three-dimensional culture of mesenchymal stem cells using various commercially available three-dimensional culture microcarriers.

[0129] It should be understood that the method of culturing mesenchymal stem cells using the mesenchymal stem cell serum-free medium of the present invention should not be limited to the embodiments described above. All mesenchymal stem cell culturing methods using the mesenchymal stem cell serum-free medium of the present invention should fall within the scope of the present invention.

[0130] Use of mesenchymal stem cell serum-free culture medium in culturing mesenchymal stem cells

[0131] In another aspect, the present invention provides a use of a serum-free medium for mesenchymal stem cells in culturing mesenchymal stem cells. In some embodiments, the culture is a two-dimensional culture. In some embodiments, the culture is a three-dimensional culture.

[0132] Example

[0133] The present invention will be described in further detail below by way of examples and in conjunction with the accompanying drawings. Unless otherwise stated, the methods and materials of the embodiments described below are conventional products that can be purchased commercially. Those skilled in the art will appreciate that the methods and materials described below are exemplary only and should not be construed as limiting the scope of the present invention.

[0134] The platelet lysate used in the following examples was EliteGro-adv purchased from EliteCell Biomedical Corp.

[0135] Example 1. Effects of different basal culture media on MSCs two-dimensional culture

[0136] The components and concentrations of culture media A, B, C, and D are as follows:

[0137] Human umbilical cord mesenchymal stem cells P5 were revived and inoculated (inoculation volume 2×10 5 The cells were cultured in T25 flasks for 3 days, and the cell number, proliferation rate, cell viability, and cell diameter were measured. The results showed that in Group D, cells using α-MEM increased by 14.3 times, significantly better than in the other groups (see Table 1). However, the proliferation rates of Groups B and C were both over 10 times. Therefore, D / F12, α-MEM + DMEM (1:1), and α-MEM can be used as basal media, with α-MEM being the preferred basal medium.

[0138] Table 1 Cell culture status on the third day of two-dimensional culture in Example 1

[0139] Example 2. Effects of different concentrations of glutamine on two-dimensional and three-dimensional culture of MSCs

[0140] The components and concentrations of culture media E and F are as follows:

[0141] Human umbilical cord mesenchymal stem cells P5 were revived and inoculated (inoculation volume 2×10 5 ) in T25 culture flasks, cultured for 3 days, and inoculated (inoculation size 50×10 5 / The cells were cultured in 6-well plates (microcarriers 20 mg / well) without cell attachment coating in three dimensions, with a culture medium volume of 8 ml and an intermediate speed culture (40 rpm, 5 min; 1 rpm, 2 h). After 1 day (day 1), the rotation speed was adjusted to a constant 40 rpm and cultured for another 3 days. The cell number, proliferation times and cell viability were detected. The experimental results showed that the two-dimensional cell proliferation effect of group F using 4 mM L-glutamine was significantly better than that of group E (see Table 2), but the cell proliferation of groups E and F reached more than 10 times. When group F used 4 mM L-glutamine, the three-dimensional culture effect was equivalent to that of group E. Therefore, L-glutamine 2-4 mM can be selected to ensure both two-dimensional and three-dimensional culture effects. L-glutamine 4 mM is preferred.

[0142] Table 2: Culture conditions of two-dimensional and three-dimensional cells on day 3 in Example 2

[0143] Example 3. Effects of different concentrations of hydrocortisone on two-dimensional and three-dimensional culture of MSCs

[0144] The components and concentrations of culture media G, H, I, J, and K are as follows:

[0145] Human umbilical cord mesenchymal stem cells P5 were revived and inoculated (inoculation volume 2×10 5 Cells were cultured in T25 flasks for 3 days, and the cell number, proliferation rate, and cell diameter were measured. The experimental results showed that cell proliferation reached its peak at 500 μg / L hydrocortisone, and further increases in concentration did not increase cell proliferation (see Table 3-1). Cell proliferation could reach more than 10-fold at concentrations of 5-5000 μg / L hydrocortisone. Therefore, a concentration of 5-5000 μg / L hydrocortisone is recommended, with 500 μg / L being the preferred concentration.

[0146] Table 3-1 Cell culture status on the third day of two-dimensional culture in Example 3

[0147] Human umbilical cord mesenchymal stem cells P3 were revived and inoculated (inoculation volume 2×10 5 ) were cultured in two dimensions in T25 culture flasks using J-1 and J medium for 3 days. Inoculation (inoculation size 2.5×10 6) were cultured in 125ml spinner flasks (microcarriers 100mg) in three dimensions using J-1 and J medium in a volume of 50ml, and cultured at intermittent speeds (40 rpm for 5 minutes and 1 rpm for 2 hours). One day later (day 1), 25ml of culture medium was added, samples were counted, and stained, and the culture was maintained at a constant speed of 40 rpm for an additional 3 days. Cell number, proliferation fold, cell viability, and cell diameter were measured. The experimental results confirmed that the proliferation folds of both two-dimensional and three-dimensional cells were unaffected by changes in hydrocortisone concentration at 400 and 500 μg / L (see Table 3-2).

[0148] Table 3-2 Two-dimensional and three-dimensional cell culture conditions in Example 3

[0149] Example 4. Effects of different concentrations of platelet lysate on 2D and 3D culture of MSCs

[0150] The components and concentrations of culture medium L and M are as follows:

[0151] Human umbilical cord mesenchymal stem cells P5 were revived and inoculated (inoculation volume 2×10 5 ) were cultured in T25 culture flasks for 3 days. Inoculation (inoculation size 2.5×10 6 ) were cultured in 125ml rotating bottles (microcarriers 100mg) in three dimensions, with a culture medium volume of 50ml each, and cultured at an intermediate speed (40rpm, 5min; 1rpm, 2h). One day later (day 1), 25ml of culture medium was added, samples were taken for counting and staining, the rotation speed was adjusted to a constant 40rpm, and cultured for another 3 days. The cell number, proliferation times, cell viability and cell diameter were detected. The experimental results showed that when the platelet lysate concentration was 5% in two-dimensional culture, the cell proliferation reached more than 10 times, and when the platelet lysate concentration was 5% in three-dimensional culture, the cell proliferation reached more than 12 times (see Table 4), and the platelet lysate concentration of 5% was preferred.

[0152] Table 4 Cell culture status on day 3 of two-dimensional culture in Example 4

[0153] Example 5. Effects of different concentrations of EGF on two-dimensional and three-dimensional culture of MSCs

[0154] The components and concentrations of culture media M, M1, M2, and M3 are as follows:

[0155] Human umbilical cord mesenchymal stem cells P5 were revived and inoculated (inoculation volume 6×10 5 ) were cultured in T75 culture flasks for 3 days. Inoculation (inoculation size 5×10 5) were cultured in three dimensions in non-TC6 well plates (microcarriers 20 mg / well), with a culture medium volume of 8 ml and an intermediate speed culture (40 rpm, 5 min; 1 rpm, 2 h). One day later (day 1), the rotation speed was adjusted to a constant 40 rpm and cultured for another 3 days. The cell number, proliferation times, cell viability and cell diameter were detected. The experimental results showed that when the EGF dosage was gradually reduced to 0 in two-dimensional culture, the cell proliferation reached about 10 times, and the proliferation was not significantly affected. When the EGF dosage was gradually reduced to 0 in three-dimensional culture, the proliferation was more than 9 times, and when the platelet lysate was reduced to 2%, the two-dimensional and three-dimensional proliferation did not decrease significantly (see Table 5). Therefore, the optimal range of EGF dosage is 0-20 ng / ml.

[0156] Table 5 Two-dimensional and three-dimensional cell culture conditions in Example 5

[0157] Example 6. Effect of continuous passage of MSCs in two-dimensional culture

[0158] Experimental method: Human umbilical cord mesenchymal stem cells P5 were revived and inoculated (inoculation volume 2×10 5 MSCs were cultured in T25 flasks containing medium L for 3 days, then passaged in T25 flasks. Culture was continued for another 3 days and then passaged again. This process was continued until P10, with cell viability, proliferation rate, and cell diameter measured at each passage. The experimental results are shown in Figures 1-4. From P6 to P10, the proliferation rate was relatively stable, exceeding 10 times, with high cell viability and a slight increase in cell diameter with increasing passages. This demonstrates that medium L can stably culture MSCs in two dimensions.

[0159] Example 7. Comparison of the effects of two-dimensional and three-dimensional culture of MSCs

[0160] Experimental method: Human umbilical cord mesenchymal stem cells were revived at P4, cultured for 3 days, digested, counted, and then cultured in two-dimensional and three-dimensional cultures. Two-dimensional culture: 2×10 5 10,000 cells were seeded in T25 culture flasks containing medium L and N and cultured for 3 days. 3D culture: 2.5×10 6 Cells were seeded in a 125 ml spinner flask with 100 mg microcarriers in 50 ml of culture medium and cultured at varying speeds (40 rpm for 5 minutes and 1 rpm for 2 hours). One day later (day 1), 25 ml of culture medium was added, the culture speed was adjusted to a constant 40 rpm, and culture was continued for another 3 days. Medium N was a commercial medium from Biological Industries (Cat. No. 05-200-1A+PLTGOLD010R). The experimental results are shown in Table 6. Medium L showed good results in both 2D and 3D cultures, while Medium N was only moderately effective in 2D cultures and less effective in 3D cultures.

[0161] Table 6 Comparison of 2D and 3D MSCs culture effects in Example 6

[0162] Example 8. Effect of three-dimensional continuous passage of MSCs

[0163] Human umbilical cord mesenchymal stem cells P3 were revived and inoculated (inoculation volume 6×10 5 ) in a T75 culture flask containing medium L. After culturing for 3 days, the cells were inoculated into a 125 ml spinner flask with a cell inoculation size of 2.5 × 10 6 The cells were cultured with 100 mg microcarriers in 50 ml of medium N and incubated at an intermediate speed (40 rpm for 5 minutes, then 1 rpm for 2 hours). One day later (day 1), 25 ml of medium was added, samples were taken for counting and staining, and the culture speed was adjusted to a constant 40 rpm. After another three days of incubation, cells were stained and counted, and then serially passaged to P7. The results showed that using medium L, even after three consecutive passages, the proliferation rate remained above 10-fold, cell viability was high, and cells maintained a good condition (see Table 7 and Figure 5).

[0164] Table 7 Cell culture conditions on day 1 and day 4 of three-dimensional culture P7 in Example 7

[0165] Example 9. Culture effects of MSCs from different sources

[0166] Experimental methods: Resuscitated P4 human umbilical cord mesenchymal stem cells (UCMSCs), human adipose tissue mesenchymal stem cells (ADMSCs), and human dental pulp mesenchymal stem cells (DPMSCs) were cultured for 3 days, digested, counted, and then cultured in two-dimensional and three-dimensional cultures. 5 10,000 MSCs from different sources were seeded in T25 culture flasks containing medium L and cultured for 3 days. Three-dimensional culture: 2.5×10 6 MSCs from different sources were seeded in 125ml spinner flasks with 100mg microcarriers in 50ml of culture medium. Culture was performed at varying speeds (40 rpm for 5 minutes and 1 rpm for 2 hours). After one day (day 1), 25ml of culture medium was added, the rotational speed was adjusted to a constant 40 rpm, and culture was continued for another 3 days. The experimental results are shown in Table 8 and Figure 6. All cells exhibited good culture performance in both 2D and 3D media. Therefore, Medium L is suitable for culturing UCMSCs, ADMSCs, and DPMSCs in both 2D and 3D formats.

[0167] Table 8 Two-dimensional and three-dimensional culture of MSCs from different sources

[0168] The embodiments of the present invention are not limited to the above embodiments. Without departing from the spirit and scope of the present invention, ordinary technicians in this field can make various changes and improvements to the present invention in form and details, and these are all considered to fall within the scope of protection of the present invention.

Claims

1. A mesenchymal stem cell serum-free medium, comprising the following components and the contents thereof are as follows: based on the total volume of the mesenchymal stem cell serum-free medium, 2 . The serum-free medium for mesenchymal stem cells according to claim 1 , wherein the basal medium is selected from the group consisting of α-MEM medium, D / F12 medium and DMEM medium. 3 . The serum-free medium for mesenchymal stem cells according to claim 1 , wherein the content of the platelet lysate is 5% (v / v). The mesenchymal stem cell serum-free medium according to claim 1 or 2, wherein the content of L-glutamine is 4 mM. The serum-free medium for mesenchymal stem cells according to claim 1 or 2, wherein the content of hydrocortisone is 500 μg / L.

6. The mesenchymal stem cell serum-free medium according to claim 1 or 2, comprising the following components and the contents thereof are as follows: based on the total volume of the mesenchymal stem cell serum-free medium, 7. A method for preparing a serum-free medium for mesenchymal stem cells according to any one of claims 1 to 6, comprising: 1) adding the other components except platelet lysate into the basal culture medium in proportion; and 2) Add platelet lysate according to the proportion.

8. A method for preparing a serum-free medium for mesenchymal stem cells according to any one of claims 1 to 6, comprising: 1) mixing the other components except the basic culture medium in proportion to prepare a nutrient supplement composition; and 2) Adding the nutrient supplement preparation prepared in step 1) into the basal culture medium preparation.

9. A method for culturing mesenchymal stem cells, wherein the mesenchymal stem cell serum-free medium according to any one of claims 1 to 6 is used for culturing.

10. The method for culturing mesenchymal stem cells according to claim 9, wherein the culturing method is a two-dimensional culturing method, comprising the following steps: 1) Mixing the cell suspension containing cells and the complete medium of mesenchymal stem cells evenly; 2) Collect cells and resuspend them in mesenchymal stem cell complete medium; 3) inoculating the cells into a cell culture container, adding a complete medium for mesenchymal stem cells, and culturing the container in an incubator; and 4) harvesting cells; Wherein, the mesenchymal stem cell complete culture medium is a mesenchymal stem cell serum-free culture medium according to any one of claims 1 to 6.

11. The method for culturing mesenchymal stem cells according to claim 9, wherein the culturing method is a three-dimensional culturing method, comprising the following steps: 1) Preparing microcarriers: placing microcarriers in a culture container, optionally, transferring the microcarriers to the culture container after swelling with liquid in advance, adding complete medium of mesenchymal stem cells, and uniformly dispersing the microcarriers; 2) Cell inoculation and culture: adding the cell suspension into a culture container and culturing it in an incubator; and 3) harvesting cells; Wherein, the mesenchymal stem cell complete culture medium is a mesenchymal stem cell serum-free culture medium according to any one of claims 1 to 6.

12. Use of the mesenchymal stem cell serum-free medium according to any one of claims 1 to 6 in culturing mesenchymal stem cells.

Citation Information

Patent Citations

  • Culture method of mesenchymal stem cells

    CN112522191A

  • Mesenchymal stem cell culture medium

    CN112608894A

  • Stem cell serum-free medium and preparation method thereof

    CN114540298A

  • Mesenchymal stem cell serum-free medium and application thereof

    CN116426470A

  • A method for obtaining mesenchymal stem cells, media, methods and composition thereof

    WO2011101834A1

Cited By

  • Serum-free polypeptide culture medium for promoting proliferation of mesenchymal stem cells and preparation method of serum-free polypeptide culture medium

    CN119709611A